(Q46516276)

English

Modelling of the concentration--effect relationship of THC on central nervous system parameters and heart rate -- insight into its mechanisms of action and a tool for clinical research and development of cannabinoids

scientific article published on 26 June 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18583433

Modelling of the concentration--effect relationship of THC on central nervous system parameters and heart rate -- insight into its mechanisms of action and a tool for clinical research and development of cannabinoids (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18583433

tetrahydrocannabinol

0 references

0 references

author name string

A Strougo

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18583433

L Zuurman

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18583433

C Roy

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18583433

J L Pinquier

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18583433

J M A van Gerven

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18583433

A F Cohen

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18583433

R C Schoemaker

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18583433

language of work or name

0 references

publication date

26 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18583433

Journal of Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18583433

22

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18583433

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18583433

717-726

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18583433

The effects of cannabinoids on the brain

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

Relevance of the application of pharmacokinetic-pharmacodynamic modelling concepts in drug development. The "wooden shoe' paradigm

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

Scopolamine model of dementia: electroencephalogram findings and cognitive performance.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

Simultaneous Modeling of Pharmacokinetics and Pharmacodynamics with a Nonparametric Pharmacodynamic Model

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

The application of the principles of clinical drug development to pharmacological challenge tests of the serotonergic system

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

Pharmacokinetics and pharmacodynamics of cannabinoids

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

Cannabinoid physiology and pharmacology: 30 years of progress.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

Towards a mechanism-based analysis of pharmacodynamic drug-drug interactions in vivo

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

Dopamine challenge tests as an indicator of psychological traits

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

Intravenous Injection in Man of Δ 9 -Tetrahydrocannabinol and 11-OH-Δ 9 -Tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

Pharmacology of cannabinoid CB1 and CB2 receptors.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

Cardiovascular effects of cannabinoids

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

Estimating impossible curves using NONMEM.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

The effects of tryptophan depletion on mood and psychiatric symptoms

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

Pharmacokinetic/pharmacodynamic assessment of tolerance to central nervous system effects of a 3 mg sustained release tablet of rilmenidine in hypertensive patients.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

The Metabolism of Δ9-Tetrahydrocannabinol and Related Cannabinoids in Man

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

Biliary excretion of delta1-tetrahydrocannabinol and its metabolites in the rat.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

Effect of intrapulmonary tetrahydrocannabinol administration in humans.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089870

21 January 2018

Identifiers

10.1177/0269881108089870

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18583433

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18583433

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46516276&oldid=2115679665"